Rossari Biotech Limited

NSEI:ROSSARI 株式レポート

時価総額:₹42.9b

Rossari Biotech 過去の業績

過去 基準チェック /56

Rossari Biotechは、平均年間16%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間14.6% 13.4%収益成長率で 成長しています。 Rossari Biotechの自己資本利益率は12.4%であり、純利益率は7.2%です。

主要情報

16.0%

収益成長率

13.5%

EPS成長率

Chemicals 業界の成長17.7%
収益成長率13.4%
株主資本利益率12.4%
ネット・マージン7.2%
前回の決算情報30 Sep 2024

最近の業績更新

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

収支内訳

Rossari Biotech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NSEI:ROSSARI 収益、費用、利益 ( )INR Millions
日付収益収益G+A経費研究開発費
30 Sep 2419,2451,3881,1890
30 Jun 2419,0961,3641,0720
31 Mar 2418,3061,3071,0980
31 Dec 2317,6431,2551,0840
30 Sep 2316,8981,1681,0650
30 Jun 2316,3181,0781,0310
31 Mar 2316,5591,0731,0390
31 Dec 2216,8831,0279970
30 Sep 2217,2759959570
30 Jun 2216,8661,0188550
31 Mar 2214,8309777350
31 Dec 2112,6239576100
30 Sep 2110,4389485160
30 Jun 218,3108924620
31 Mar 217,0938024560
31 Dec 206,5077294230
30 Sep 206,0316954150
30 Jun 205,8186663890
31 Mar 206,0016533960
31 Mar 195,1624573010
31 Mar 182,9222542130
31 Mar 172,3501431950

質の高い収益: ROSSARIは 高品質の収益 を持っています。

利益率の向上: ROSSARIの現在の純利益率 (7.2%)は、昨年(6.9%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: ROSSARIの収益は過去 5 年間で年間16%増加しました。

成長の加速: ROSSARIの過去 1 年間の収益成長率 ( 18.8% ) は、5 年間の平均 ( 年間16%を上回っています。

収益対業界: ROSSARIの過去 1 年間の収益成長率 ( 18.8% ) はChemicals業界8%を上回りました。


株主資本利益率

高いROE: ROSSARIの 自己資本利益率 ( 12.4% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘